Immediate Impact
4 standout
Citing Papers
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
2023 Standout
Biomarker-guided therapy for colorectal cancer: strength in complexity
2019 Standout
Works of Lisette Stork being referenced
Standard anthracycline-based vs. docetaxel-capecitabine in early breast cancer: Results from the chemotherapy randomization (R-C) of EORTC 10041/ BIG 3-04 MINDACT phase III trial.
2017
Genomic classifier (ColoPrint) to predict outcome and chemotherapy benefit in stage II and III colon cancer patients.
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Lisette Stork | 10 | 17 | 9 | 10 | 20 | |
| Sladjana Filipovic | 7 | 20 | 7 | 11 | 28 | |
| Pablo Kalfayan | 14 | 7 | 8 | 7 | 17 | |
| Rim S. Kim | 5 | 21 | 7 | 7 | 24 | |
| Jolanta Kalniņa | 17 | 7 | 5 | 10 | 35 | |
| Sarah K. Macklin‐Mantia | 7 | 7 | 6 | 6 | 21 | |
| Marko Miladinov | 6 | 12 | 6 | 6 | 24 | |
| Marianne Dubard-Gault | 8 | 7 | 8 | 6 | 20 | |
| Sven Mattern | 7 | 16 | 7 | 12 | 34 | |
| Shehnarz Salindera | 4 | 6 | 8 | 8 | 21 | |
| Thibaud Koessler | 7 | 17 | 9 | 12 | 18 |
All Works
Loading papers...